BIOMAT Database Logo BIOMAT Database Logo

Hyperprolactinemia and galactorrhea with standard-dose famotidine therapy. 1995

K Güven, and F Kelestimur

UI MeSH Term Description Entries
D006966 Hyperprolactinemia Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8) Prolactin Hypersecretion Syndrome,Prolactin, Inappropriate Secretion,Hyperprolactinaemia,Inappropriate Prolactin Secretion,Inappropriate Prolactin Secretion Syndrome,Hyperprolactinemias,Hypersecretion Syndrome, Prolactin,Inappropriate Secretion Prolactin,Prolactin Secretion, Inappropriate,Secretion Prolactin, Inappropriate,Secretion, Inappropriate Prolactin,Syndrome, Prolactin Hypersecretion
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D005260 Female Females
D005687 Galactorrhea Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA. Galactorrheas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D015738 Famotidine A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. Famotidine Hydrochloride,MK-208,Pepcid,YM-11170,MK 208,MK208,YM 11170,YM11170

Related Publications

K Güven, and F Kelestimur
[Hyperprolactinemia and galactorrhea].
October 1999, Revista clinica espanola,
K Güven, and F Kelestimur
Galactorrhea and hyperprolactinemia.
December 1983, Obstetrical & gynecological survey,
K Güven, and F Kelestimur
Hyperprolactinemia, galactorrhea, and atenolol.
March 1992, Annals of internal medicine,
K Güven, and F Kelestimur
Amenorrhea, galactorrhea, and hyperprolactinemia.
June 1985, The Journal of the American Osteopathic Association,
K Güven, and F Kelestimur
[Galactorrhea and hyperprolactinemia: update].
November 1982, Revue medicale de Bruxelles,
K Güven, and F Kelestimur
Galactorrhea and hyperprolactinemia associated with amoxapine therapy. Report of a case.
October 1979, JAMA,
K Güven, and F Kelestimur
[Correlations between hyperprolactinemia and galactorrhea].
November 1989, Ginecologia y obstetricia de Mexico,
K Güven, and F Kelestimur
Verapamil-induced hyperprolactinemia and galactorrhea.
July 1981, Annals of internal medicine,
K Güven, and F Kelestimur
[Drug-induced hyperprolactinemia and galactorrhea].
December 1992, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
K Güven, and F Kelestimur
HMG/hCG galactorrhea and hyperprolactinemia.
March 1983, Fertility and sterility,
Copied contents to your clipboard!